Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Witkowski

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
The Lancet. Infectious Diseases|March 20, 2025
14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy studyVirak Eng, Dysoley Lek, Sitha Sin, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
High versus low dose of 14 days treatment of primaquine in <i>Plasmodium vivax</i> infected patients in Cambodia: a randomised open-label efficacy studyVirak Eng, Dysoley Lek, Sitha Sin, et al.
Plos Neglected Tropical Diseases|November 27, 2013
Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strainsDidier Menard, Ernest R Chan, Christophe Benedet, et al.
Malaria Journal|May 30, 2013
G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patientsNimol Khim, Christophe Benedet, Saorin Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2019
Identification and Characterization of Functional Human Monoclonal Antibodies to <i>Plasmodium vivax</i> Duffy-Binding ProteinLenore L Carias, Sebastien Dechavanne, Vanessa C Nicolete, et al.
Malaria Journal|July 13, 2019
High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in SomaliaMarian Warsame, Abdillahi Mohamed Hassan, Abdikarim Hussein Hassan, et al.
NPJ Vaccines|November 23, 2024
The PvRBP2b-TfR1 interaction is not essential for reticulocytes invasion by Plasmodium vivax isolates from CambodiaLionel B Feufack-Donfack, Léa Baldor, Camille Roesch, et al.
Science (New York, N.Y.)|December 16, 2014
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolatesJudith Straimer, Nina F Gnädig, Benoit Witkowski, et al.
The Lancet. Infectious Diseases|September 17, 2013
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studiesBenoit Witkowski, Chanaki Amaratunga, Nimol Khim, et al.
BMC Medicine|December 24, 2015
Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigationsValentine Duru, Nimol Khim, Rithea Leang, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
The Lancet. Infectious Diseases|March 20, 2025
14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy studyVirak Eng, Dysoley Lek, Sitha Sin, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
High versus low dose of 14 days treatment of primaquine in <i>Plasmodium vivax</i> infected patients in Cambodia: a randomised open-label efficacy studyVirak Eng, Dysoley Lek, Sitha Sin, et al.
Plos Neglected Tropical Diseases|November 27, 2013
Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strainsDidier Menard, Ernest R Chan, Christophe Benedet, et al.
Malaria Journal|May 30, 2013
G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patientsNimol Khim, Christophe Benedet, Saorin Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2019
Identification and Characterization of Functional Human Monoclonal Antibodies to <i>Plasmodium vivax</i> Duffy-Binding ProteinLenore L Carias, Sebastien Dechavanne, Vanessa C Nicolete, et al.
Malaria Journal|July 13, 2019
High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in SomaliaMarian Warsame, Abdillahi Mohamed Hassan, Abdikarim Hussein Hassan, et al.
NPJ Vaccines|November 23, 2024
The PvRBP2b-TfR1 interaction is not essential for reticulocytes invasion by Plasmodium vivax isolates from CambodiaLionel B Feufack-Donfack, Léa Baldor, Camille Roesch, et al.
Science (New York, N.Y.)|December 16, 2014
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolatesJudith Straimer, Nina F Gnädig, Benoit Witkowski, et al.
The Lancet. Infectious Diseases|September 17, 2013
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studiesBenoit Witkowski, Chanaki Amaratunga, Nimol Khim, et al.
BMC Medicine|December 24, 2015
Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigationsValentine Duru, Nimol Khim, Rithea Leang, et al.
Pageof 9